AOP Health Fills New Leadership Positions

Vienna, 17.12.2024. The globally operating pharmaceutical company AOP Health is gearing up for continued growth. To this end, the new position of Vice President of Market Access, Public Affairs & Patient Advocacy has been created and filled, while the role of Area Director DACH has been reassigned.

Mag. Bettina Bernhard, MIM MBA, became Vice President of Market Access, Public Affairs & Patient Advocacy

Since June 2024 Bettina Bernhard has been heading the Market Access, Public Affairs, and Patient Advocacy divisions at AOP Health. In this role, she is responsible for ensuring that the company's products are accessible to patients in various markets, fostering and expanding relationships with political decision-makers and European interest groups, and promoting close collaboration with patient organizations.

For the molecular geneticist and economist, her work goes beyond numbers and strategies. She sees her department's mission as ensuring that the right therapies reach the right patients at a fair price.

Bernhard believes the key to success lies in collaboration across all company functions: 

Michael Lange, PhD, is Area Director of the DACH-Region

Since June 2024, biophysicist and biologist Michael Lange has been leading AOP Health’s DACH region - one of the company’s most significant growth regions globally. In his new role, Lange aims to look beyond national borders and leverage synergies between Germany, Austria, and Switzerland. He states:

Another focus of his work lies in digitalization. For instance, Lange is advancing the implementation of integrated multichannel marketing approaches to optimally link marketing, sales, and medical functions. In addition to external market strategy, Lange emphasizes organizational development within the region.

About AOP Health

The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. The claim “Needs. Science. Trust.” sums up the foundation of the Group’s success: establishing trust through a continually high level of investment in research and development and a highly consistent and pragmatic orientation towards the needs of all stakeholders – especially the patients and their families as well as the healthcare professionals treating them.

Press Contact.

Mag. Nina Roth, MAS

Head of Corporate Communications
nina.roth[at]aop-health.com

Photocredit Portraits: "AOP Health/Studio Koekart"